Evidence map›Paper›PMID 36295842›Full record

ArticleMetabolites2022

Acetyl Co-A Carboxylase Inhibition Halts Hyperglycemia Induced Upregulation of De Novo Lipogenesis in Podocytes and Proximal Tubular Cells.

Pradeep Kayampilly, Nancy Roeser, Thekkelnaycke M Rajendiran, Subramaniam Pennathur, Farsad Afshinnia

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pradeep KayampillyDepartment of Internal Medicine-Nephrology, University of Michigan, Ann Arbor, MI 48105, USA.
Nancy RoeserDepartment of Internal Medicine-Nephrology, University of Michigan, Ann Arbor, MI 48105, USA.
Thekkelnaycke M RajendiranMichigan Regional Comprehensive Metabolomics Resource Core, University of Michigan, Ann Arbor, MI 48105, USA.
Subramaniam PennathurDepartment of Internal Medicine-Nephrology, University of Michigan, Ann Arbor, MI 48105, USA.ORCID 0000-0003-3628-6883
Farsad AfshinniaDepartment of Internal Medicine-Nephrology, University of Michigan, Ann Arbor, MI 48105, USA.ORCID 0000-0003-3051-3141
University of Michigan · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Martin G Myers · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joyce Lee · 2010 to 2026
$20.3M
Integrated Systems Biology Approach to Diabetic Microvascular ComplicationsR24DK082841 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABCOUWER, STEVEN F, BROSIUS, FRANK C · 2008 to 2020
$13.1M
University of Michigan O'Brien Kidney Translational Core CenterP30DK081943 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PENNATHUR, SUBRAMANIAM · 2008 to 2022
$12.9M
Prognostic Biomarkers in Chronic Kidney DiseaseK08DK106523 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AFSHINNIA, FARSAD · 2015 to 2019
$789k
Lipidomic Predictors of Diabetic Kidney Disease Progression in Patients with Type-1 DiabetesR03DK121941 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AFSHINNIA, FARSAD · 2019 to 2020
$169k
Role of Acetyl CoA carboxylase in type 2 diabetic kidney diseaseR56DK126647 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AFSHINNIA, FARSAD · 2020 to 2020
$101k
NIDDK NIH HHS K08 DK106523NIDDK NIH HHS K08DK106523, R03DK121941, R56DK126647, P30DK089503, P30DK081943, P30DK020572, R24DK082841NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK081943NIDDK NIH HHS P30 DK089503NIDDK NIH HHS R03 DK121941NIDDK NIH HHS R24 DK082841NIDDK NIH HHS R56 DK126647
6 · The paper itself

Abstract

The effect of glycemic stress on de novo lipogenesis (DNL) in podocytes and tubular epithelial cells is understudied. This study is aimed (A) to show the effect of glycemic stress on DNL, and (B) to assess the effect of acetyl-Co A (ACC) inhibition on halting upregulation of DNL, on the expression of other lipid regulatory genes in the DNL pathway, and on markers of fibrosis and apoptosis in podocytes and tubular epithelial cells. We used cultured mouse primary tubular epithelial cells, mouse proximal tubular (BUMPT) cells, and immortal mouse podocytes and measured their percentage of labeled

Indexed as

acetyl Co-A carboxylasede novo lipogenesisdiabeteslipid metabolismpalmitatepodocytestubules

Identifiers

PMID36295842
PMCPMC9610518
OpenAlexW4303857123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.